Growth Metrics

Biogen (BIIB) Retained Earnings (2016 - 2025)

Biogen has reported Retained Earnings over the past 17 years, most recently at $20.6 billion for Q4 2025.

  • Quarterly results put Retained Earnings at $20.6 billion for Q4 2025, up 6.71% from a year ago — trailing twelve months through Dec 2025 was $20.6 billion (up 6.71% YoY), and the annual figure for FY2025 was $20.6 billion, up 6.71%.
  • Retained Earnings for Q4 2025 was $20.6 billion at Biogen, roughly flat from $20.6 billion in the prior quarter.
  • Over the last five years, Retained Earnings for BIIB hit a ceiling of $20.6 billion in Q3 2025 and a floor of -$238.1 million in Q2 2025.
  • Median Retained Earnings over the past 5 years was -$152.6 million (2023), compared with a mean of $3.8 billion.
  • Biggest five-year swings in Retained Earnings: plummeted 128.97% in 2021 and later surged 14239.74% in 2025.
  • Biogen's Retained Earnings stood at -$106.7 million in 2021, then plummeted by 54.55% to -$164.9 million in 2022, then soared by 10789.87% to $17.6 billion in 2023, then increased by 9.26% to $19.3 billion in 2024, then rose by 6.71% to $20.6 billion in 2025.
  • The last three reported values for Retained Earnings were $20.6 billion (Q4 2025), $20.6 billion (Q3 2025), and -$238.1 million (Q2 2025) per Business Quant data.